OUR PRODUCTS

MOBILE APPS

GENERAL INFO

IMAB

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

I-MAB (IMAB) Earnings Date & Reports

I-MAB is a clinical-stage biotech company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IMAB is expected to report earnings to fall 22.86% to -5 cents per share on November 13

Q3'25

Est.

$-0.05

Q2'25

Missed

by $0.03

Q1'25

Beat

by $0.09

Q4'24

Est.

$-0.06

Q3'24

Missed

by $0.04

The last earnings report on August 20 showed earnings per share of -7 cents, missing the estimate of -3 cents. With 3.48M shares outstanding, the current market capitalization sits at 415.65M.

View a ticker or compare two or three

Compare

IMAB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For IMAB
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMAB showed earnings on August 20, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a clinical stage biopharmaceutical company, which engages in developing and commercialization of differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

555 West Haiyang Road

Phone

+86 2160578000

Employees

318

Web

https://www.i-mabbiopharma.com